Growth Metrics

Tvardi Therapeutics (TVRD) Inventory Average (2022 - 2025)

Tvardi Therapeutics' Inventory Average history spans 4 years, with the latest figure at $1.7 million for Q1 2025.

  • On a quarterly basis, Inventory Average fell 45.95% to $1.7 million in Q1 2025 year-over-year; TTM through Mar 2025 was $1.7 million, a 45.95% decrease, with the full-year FY2024 number at $2.1 million, down 26.32% from a year prior.
  • Inventory Average hit $1.7 million in Q1 2025 for Tvardi Therapeutics, up from $1.5 million in the prior quarter.
  • Over the last five years, Inventory Average for TVRD hit a ceiling of $3.5 million in Q2 2023 and a floor of $1.5 million in Q4 2024.
  • Historically, Inventory Average has averaged $2.5 million across 4 years, with a median of $2.6 million in 2022.
  • Biggest five-year swings in Inventory Average: soared 55.53% in 2023 and later plummeted 54.03% in 2024.
  • Tracing TVRD's Inventory Average over 4 years: stood at $2.1 million in 2022, then soared by 55.53% to $3.3 million in 2023, then plummeted by 54.03% to $1.5 million in 2024, then increased by 9.05% to $1.7 million in 2025.
  • Business Quant data shows Inventory Average for TVRD at $1.7 million in Q1 2025, $1.5 million in Q4 2024, and $1.9 million in Q3 2024.